Статті в журналах з теми "Inhibition covalente"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Inhibition covalente".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Aljoundi, Aimen, Ahmed El Rashedy, Patrick Appiah-Kubi та Mahmoud E. S. Soliman. "Coupling of HSP72 α-Helix Subdomains by the Unexpected Irreversible Targeting of Lysine-56 over Cysteine-17; Coevolution of Covalent Bonding". Molecules 25, № 18 (16 вересня 2020): 4239. http://dx.doi.org/10.3390/molecules25184239.
Liu, S. Q., and P. A. Knauf. "Lys-430, site of irreversible inhibition of band 3 Cl- flux by eosin-5-maleimide, is not at the transport site." American Journal of Physiology-Cell Physiology 264, no. 5 (May 1, 1993): C1155—C1164. http://dx.doi.org/10.1152/ajpcell.1993.264.5.c1155.
Yang, Jianhong, Yong Li, Wei Yan, Weimin Li, Qiang Qiu, Haoyu Ye та Lijuan Chen. "Covalent modification of Cys-239 in β-tubulin by small molecules as a strategy to promote tubulin heterodimer degradation". Journal of Biological Chemistry 294, № 20 (2 квітня 2019): 8161–70. http://dx.doi.org/10.1074/jbc.ra118.006325.
Maksimenko, A. V., and R. Sh Beabealashvili. "Theoretical Grounding and Formation of Experimental Approaches to Hyaluronidase Structure Consolidation due to Its Computational Interactions with Shortchain Glycosaminoglycan Ligands." Биоорганическая химия 49, no. 4 (July 1, 2023): 369–83. http://dx.doi.org/10.31857/s0132342323020161.
Bhatia, Sumeena, Steven C. Almo, Stanley G. Nathenson, and Richard J. Hodes. "Dynamic equilibrium of B7-1 dimers and monomers is important for regulation of TCR/CD28 – mediated T cell activation (33.28)." Journal of Immunology 182, no. 1_Supplement (April 1, 2009): 33.28. http://dx.doi.org/10.4049/jimmunol.182.supp.33.28.
Kuznetsova, Anastasiya, Philipp Klein, and Till Opatz. "Halogenated 2,1,3-benzoxadiazoles as Potential Fluorescent Warheads for Covalent Protease Inhibitors." Proceedings 9, no. 1 (November 14, 2018): 54. http://dx.doi.org/10.3390/ecsoc-22-05670.
Hognon, Cécilia, Marco Marazzi, and Cristina García-Iriepa. "Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease." International Journal of Molecular Sciences 23, no. 10 (May 23, 2022): 5855. http://dx.doi.org/10.3390/ijms23105855.
Bisconte, Angelina, Ronald Hill, Michael Bradshaw, Erik Verner, David Finkle, Ken Brameld, Jens Funk, David Goldstein, and Phil Nunn. "Efficacy in collagen induced arthritis models with a selective, reversible covalent Bruton’s tyrosine kinase inhibitor PRN473 is driven by durable target occupancy rather than extended plasma exposure (THER5P.904)." Journal of Immunology 194, no. 1_Supplement (May 1, 2015): 139.6. http://dx.doi.org/10.4049/jimmunol.194.supp.139.6.
Beck, Philipp, Christian Dubiella, and Michael Groll. "Covalent and non-covalent reversible proteasome inhibition." Biological Chemistry 393, no. 10 (October 1, 2012): 1101–20. http://dx.doi.org/10.1515/hsz-2012-0212.
Piestrzeniewicz, Mariola K., Dorota Wilmańska, Janusz Szemraj, Kazimierz Studzian, and Marek Gniazdowski. "Interactions of Novel Morpholine and Hexamethylene Derivatives of Anthracycline Antibiotics with DNA." Zeitschrift für Naturforschung C 59, no. 9-10 (October 1, 2004): 739–48. http://dx.doi.org/10.1515/znc-2004-9-1020.
Müller, Patrick, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten, et al. "Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study." International Journal of Molecular Sciences 24, no. 8 (April 13, 2023): 7226. http://dx.doi.org/10.3390/ijms24087226.
Gerling, Katharina, Sabrina Ölschläger, Meltem Avci-Adali, Bernd Neumann, Ernst Schweizer, Christian Schlensak, Hans-Peter Wendel, and Sandra Stoppelkamp. "A Novel C1-Esterase Inhibitor Oxygenator Coating Prevents FXII Activation in Human Blood." Biomolecules 10, no. 7 (July 13, 2020): 1042. http://dx.doi.org/10.3390/biom10071042.
Stellmacher, Lena, Tatyana Sandalova, Sarah Schneider, Gunter Schneider, Georg A. Sprenger, and Anne K. Samland. "Novel mode of inhibition byD-tagatose 6-phosphate through a Heyns rearrangement in the active site of transaldolase B variants." Acta Crystallographica Section D Structural Biology 72, no. 4 (March 24, 2016): 467–76. http://dx.doi.org/10.1107/s2059798316001170.
Betori, Rick C., Yue Liu, Rama K. Mishra, Scott B. Cohen, Stephen J. Kron, and Karl A. Scheidt. "Targeted Covalent Inhibition of Telomerase." ACS Chemical Biology 15, no. 3 (February 4, 2020): 706–17. http://dx.doi.org/10.1021/acschembio.9b00945.
Ghosh, Avick Kumar, Indranil Samanta, Anushree Mondal, and Wenshe Ray Liu. "Covalent Inhibition in Drug Discovery." ChemMedChem 14, no. 9 (March 26, 2019): 889–906. http://dx.doi.org/10.1002/cmdc.201900107.
Rao, AK, and MA Kowalska. "ADP-induced platelet shape change and mobilization of cytoplasmic ionized calcium are mediated by distinct binding sites on platelets: 5'- p-fluorosulfonylbenzoyladenosine is a weak platelet agonist." Blood 70, no. 3 (September 1, 1987): 751–56. http://dx.doi.org/10.1182/blood.v70.3.751.751.
Rao, AK, and MA Kowalska. "ADP-induced platelet shape change and mobilization of cytoplasmic ionized calcium are mediated by distinct binding sites on platelets: 5'- p-fluorosulfonylbenzoyladenosine is a weak platelet agonist." Blood 70, no. 3 (September 1, 1987): 751–56. http://dx.doi.org/10.1182/blood.v70.3.751.bloodjournal703751.
Bjij, Imane, Fisayo A. Olotu, Clement Agoni, Emmanuel Adeniji, Shama Khan, Ahmed El Rashedy, Driss Cherqaoui, and Mahmoud E. S. Soliman. "Covalent Inhibition in Drug Discovery: Filling the Void in Literature." Current Topics in Medicinal Chemistry 18, no. 13 (October 4, 2018): 1135–45. http://dx.doi.org/10.2174/1568026618666180731161438.
Strelow, John M. "A Perspective on the Kinetics of Covalent and Irreversible Inhibition." SLAS DISCOVERY: Advancing the Science of Drug Discovery 22, no. 1 (October 5, 2016): 3–20. http://dx.doi.org/10.1177/1087057116671509.
Kilbourn, R., and G. Lopez-Berestein. "Protease inhibitors block the macrophage-mediated inhibition of tumor cell mitochondrial respiration." Journal of Immunology 144, no. 3 (February 1, 1990): 1042–45. http://dx.doi.org/10.4049/jimmunol.144.3.1042.
Colman, RW, WR Figures, LM Scearce, AM Strimpler, FX Zhou, and AK Rao. "Inhibition of collagen-induced platelet activation by 5'-p- fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides." Blood 68, no. 2 (August 1, 1986): 565–70. http://dx.doi.org/10.1182/blood.v68.2.565.565.
Colman, RW, WR Figures, LM Scearce, AM Strimpler, FX Zhou, and AK Rao. "Inhibition of collagen-induced platelet activation by 5'-p- fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides." Blood 68, no. 2 (August 1, 1986): 565–70. http://dx.doi.org/10.1182/blood.v68.2.565.bloodjournal682565.
Tian, Yafeng, Mi Zhang, Panpan Heng, Hua Hou, and Baoshan Wang. "Computational Investigations on Reaction Mechanisms of the Covalent Inhibitors Ponatinib and Analogs Targeting the Extracellular Signal-Regulated Kinases." International Journal of Molecular Sciences 24, no. 20 (October 16, 2023): 15223. http://dx.doi.org/10.3390/ijms242015223.
Zhou, X. Edward, Kelly Suino-Powell, Chad R. Schultz, Bilal Aleiwi, Joseph S. Brunzelle, Jared Lamp, Irving E. Vega, Edmund Ellsworth, André S. Bachmann, and Karsten Melcher. "Structural basis of binding and inhibition of ornithine decarboxylase by 1-amino-oxy-3-aminopropane." Biochemical Journal 478, no. 23 (December 6, 2021): 4137–49. http://dx.doi.org/10.1042/bcj20210647.
Kinoshita, T., A. W. Dodds, S. K. A. Law, and K. Inoue. "The low C5 convertase activity of the C4A6 allotype of human complement component C4." Biochemical Journal 261, no. 3 (August 1, 1989): 743–48. http://dx.doi.org/10.1042/bj2610743.
Stevic, Ivan, Howard H. W. Chan, Ankush Chander, Leslie R. Berry, and Anthony K. C. Chan. "Covalently linking heparin to antithrombin enhances prothrombinase inhibition on activated platelets." Thrombosis and Haemostasis 109, no. 06 (2013): 1016–24. http://dx.doi.org/10.1160/th12-10-0766.
Sim, E., A. W. Dodds, and A. Goldin. "Inhibition of the covalent binding reaction of complement component C4 by penicillamine, an anti-rheumatic agent." Biochemical Journal 259, no. 2 (April 15, 1989): 415–19. http://dx.doi.org/10.1042/bj2590415.
Lu, Jia-Hui, Zhen Li, Jia-Hui Chen, Shu-Liang Li, Jie-Hao He, Song Gu, Bo-Wen Liu, Li Chen, and Yu-Zhong Wang. "Adaptable Phosphate Networks towards Robust, Reprocessable, Weldable, and Alertable-Yet-Extinguishable Epoxy Vitrimer." Research 2022 (October 6, 2022): 1–12. http://dx.doi.org/10.34133/2022/9846940.
Ruddraraju, Kasi Viswanatharaju, and Zhong-Yin Zhang. "Covalent inhibition of protein tyrosine phosphatases." Molecular BioSystems 13, no. 7 (2017): 1257–79. http://dx.doi.org/10.1039/c7mb00151g.
Zhao, Yuguang, Fredrik Svensson, David Steadman, Sarah Frew, Amy Monaghan, Magda Bictash, Tiago Moreira, et al. "Structural Insights into Notum Covalent Inhibition." Journal of Medicinal Chemistry 64, no. 15 (July 22, 2021): 11354–63. http://dx.doi.org/10.1021/acs.jmedchem.1c00701.
Westover, Kenneth D., Pasi A. Jänne, and Nathanael S. Gray. "Progress on Covalent Inhibition of KRASG12C." Cancer Discovery 6, no. 3 (March 2016): 233–34. http://dx.doi.org/10.1158/2159-8290.cd-16-0092.
Jacobs, Amy. "Covalent Inhibition of HIV Membrane Fusion." Biophysical Journal 96, no. 3 (February 2009): 359a. http://dx.doi.org/10.1016/j.bpj.2008.12.1814.
Huang, Huang, Christina A. Howard, Sergei Zari, Hyo Je Cho, Shirish Shukla, Hao Li, Juliano Ndoj, et al. "Covalent inhibition of NSD1 histone methyltransferase." Nature Chemical Biology 16, no. 12 (August 31, 2020): 1403–10. http://dx.doi.org/10.1038/s41589-020-0626-6.
Amara, Neri, Roi Mashiach, Dotan Amar, Pnina Krief, Stéphane A. H. Spieser, Matthew J. Bottomley, Amir Aharoni, and Michael M. Meijler. "Covalent Inhibition of Bacterial Quorum Sensing." Journal of the American Chemical Society 131, no. 30 (August 5, 2009): 10610–19. http://dx.doi.org/10.1021/ja903292v.
Kentner, Taryn A., Leslie R. Berry, and Anthony K. C. Chan. "Inhibition of Factor Xa in Prothrombinase Is Enhanced by Covalent Linkage of Antithrombin to Heparin." Blood 104, no. 11 (November 16, 2004): 1051. http://dx.doi.org/10.1182/blood.v104.11.1051.1051.
NAGUMO, Yoko, Hideaki KAKEYA, Mitsuru SHOJI, Yujiro HAYASHI, Naoshi DOHMAE, and Hiroyuki OSADA. "Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity." Biochemical Journal 387, no. 3 (April 26, 2005): 835–40. http://dx.doi.org/10.1042/bj20041355.
Jebaraj, Billy Michael Chelliah, Annika Müller, Rashmi Priyadharshini Dheenadayalan, Sascha Endres, Philipp M. Roessner, Felix Seyfried, Claudia Walliser, et al. "Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia." Blood 139, no. 6 (February 10, 2022): 859–75. http://dx.doi.org/10.1182/blood.2021011516.
Wágner, Gábor, Tamara A. M. Mocking, Albert J. Kooistra, Inna Slynko, Péter Ábrányi-Balogh, György M. Keserű, Maikel Wijtmans, Henry F. Vischer, Iwan J. P. de Esch, and Rob Leurs. "Covalent Inhibition of the Histamine H3 Receptor." Molecules 24, no. 24 (December 11, 2019): 4541. http://dx.doi.org/10.3390/molecules24244541.
Thøgersen, I. B., G. Salvesen, F. H. Brucato, S. V. Pizzo та J. J. Enghild. "Purification and characterization of an α-macroglobulin proteinase inhibitor from the mollusc Octopus vulgaris". Biochemical Journal 285, № 2 (15 липня 1992): 521–27. http://dx.doi.org/10.1042/bj2850521.
Shatan, Anastasiia B., Vitalii Patsula, Hana Macková, Andrii Mahun, Renáta Lehotská, Elena Piecková та Daniel Horák. "Silver-Sulfamethazine-Conjugated β-Cyclodextrin/Dextran-Coated Magnetic Nanoparticles for Pathogen Inhibition". Nanomaterials 14, № 4 (17 лютого 2024): 371. http://dx.doi.org/10.3390/nano14040371.
Lee, Jesang, and Seung Bum Park. "Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets." Pharmaceuticals 15, no. 12 (November 27, 2022): 1478. http://dx.doi.org/10.3390/ph15121478.
Walderveen, Maria Christina Van, Leslie Roy Berry, Helen Mary Atkinson, and Anthony Kam Chuen Chan. "Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va." Thrombosis and Haemostasis 103, no. 05 (2010): 910–19. http://dx.doi.org/10.1160/th09-07-0473.
Allgardsson, Anders, Lotta Berg, Christine Akfur, Andreas Hörnberg, Franz Worek, Anna Linusson, and Fredrik J. Ekström. "Structure of a prereaction complex between the nerve agent sarin, its biological target acetylcholinesterase, and the antidote HI-6." Proceedings of the National Academy of Sciences 113, no. 20 (May 2, 2016): 5514–19. http://dx.doi.org/10.1073/pnas.1523362113.
Lee, Chang-Uk, and Tom N. Grossmann. "Reversible Covalent Inhibition of a Protein Target." Angewandte Chemie International Edition 51, no. 35 (July 13, 2012): 8699–700. http://dx.doi.org/10.1002/anie.201203341.
Ahmed, Vanessa F., Nunzio Bottini, and Amy M. Barrios. "Covalent Inhibition of the Lymphoid Tyrosine Phosphatase." ChemMedChem 9, no. 2 (January 8, 2014): 296–99. http://dx.doi.org/10.1002/cmdc.201300404.
Stevic, Ivan, Howard H. W. Chan, Ankush Chander, Leslie R. Berry, and Anthony K. C. Chan. "Inhibition of Platelet-Prothrombianse by a Covalent Antithrombin-Heparin Complex." Blood 120, no. 21 (November 16, 2012): 2212. http://dx.doi.org/10.1182/blood.v120.21.2212.2212.
Zhou, Yuxin, Ji Tao, Dingshuainan Jin, Shiping Zhang, Yan He, and Longlong Niu. "The Inhibition Effect and Mechnism of a Thiadiazole Derivative on Q235 Carbon Steel in 1 M HCl Solution." Applied Sciences 13, no. 4 (February 6, 2023): 2103. http://dx.doi.org/10.3390/app13042103.
Buneeva, O. A., L. N. Aksenova, and A. E. Medvedev. "A Simple Approach for Pilot Analysis of Time-dependent Enzyme Inhibition: Discrimination Between Mechanism-based Inactivation and Tight Binding Inhibitor Behavior." Biomedical Chemistry: Research and Methods 3, no. 1 (2020): e00115. http://dx.doi.org/10.18097/bmcrm00115.
Wang, Qian, Guofeng Chen, Jian He, Jiameng Li, Muya Xiong, Haixia Su, Minjun Li, Hangchen Hu, and Yechun Xu. "Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease." International Journal of Molecular Sciences 24, no. 10 (May 11, 2023): 8633. http://dx.doi.org/10.3390/ijms24108633.
Abdeldayem, Ayah, Yasir S. Raouf, Stefan N. Constantinescu, Richard Moriggl, and Patrick T. Gunning. "Advances in covalent kinase inhibitors." Chemical Society Reviews 49, no. 9 (2020): 2617–87. http://dx.doi.org/10.1039/c9cs00720b.